🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective, open-label, multicenter study in previously un...
Status
Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2026-03-01
Trial ID
NCT07680933
Treatments Being Tested
This is a single-arm, prospective clinical study to evaluate the efficacy a...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-03-11
Trial ID
NCT07022223
Treatments Being Tested
This multicenter, open-label, randomized controlled trial aims to evaluate ...
Status
Recruiting
Location
Ruijin Hospital
Start Date
2024-07-10
Trial ID
NCT06496308
Treatments Being Tested
This is a multicenter, open-label, single-arm, prospective clinical study o...
Status
Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2026-02-07
Trial ID
NCT07410520
Treatments Being Tested
B-cell non-Hodgkin's lymphoma (B-NHL) is the most common type of NHL. Altho...
Status
Unknown
Location
Shandong Provincial Hospital
Start Date
2021-04-15
Trial ID
NCT05097443
This is a single arm, single center, open label pilot study of Orelabrutini...
Status
Completed
Location
Department of Hematology, Huashan Hospital, Fudan University
Start Date
2021-10-10
Trial ID
NCT05036577
Treatments Being Tested
This study aims to compare the efficacy and safety of Polatuzumab Vedotin, ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-01
Trial ID
NCT06516978
Assess the preliminary efficacy and safety of orelabrutinib in combination ...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-05-05
Trial ID
NCT07078500
Treatments Being Tested
Efficacy and Safety of Orelabrutinib Combined with Rituximab versus Lenalid...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2023-12-19
Trial ID
NCT06082102
Treatments Being Tested
The goal of this clinical trial is to test the overall response rate of Ore...
Status
Recruiting
Location
The Second Affiliated Hospital of Zhejiang University, Ningbo First Hospital
Start Date
2023-01-02
Trial ID
NCT06134284
Treatments Being Tested